CTI Life Sciences

CTI Life Sciences is a biotech venture capital firm and company builder that catalyzes nascent ideas and assets into investable, scalable, and marketable...

CTI Life Sciences

CTI Life Sciences is a biotech venture capital firm and company builder that catalyzes nascent ideas and assets into investable, scalable, and marketable biotech companies. It pursues transformative investments in the biotech industry with a therapeutic and modality agnostic approach. The firm reports 20+ years in business, 30+ investments, multiple funds raised, and a dual-pronged strategy focused on long-term value creation and expedited exits.

Website

www.ctisciences.com

linkedin.com/company/cti-lsf

General information

Firm type

Private Equity

Year founded

2006

Location

Region

North America

Country

Canada

City

Montreal

Corporate office

Montreal, Canada

Principals

Ken Pastor

Managing Partner (Founding General Partner)

Laurence Rulleau

Managing Partner

Youssef Bennani

Managing Partner

Shermaine Tilley

Managing Partner

Dana Matzen

Partner

Xin Hang

Senior Principal

Sector focus

Life SciencesVenture

Who runs investment decisions at CTI Life Sciences?

No named principals or investment committee members are disclosed in public records.

What investment stages does CTI Life Sciences target?

The firm covers early-stage seed, start-up, expansion, and late-stage venture opportunities.

Does CTI Life Sciences participate in fund commitments or only direct deals?

Available information does not specify fund commitments versus direct investments.

Which sectors does CTI Life Sciences focus on?

The firm concentrates on life sciences investments.

Where is CTI Life Sciences headquartered?

The firm is based in Montreal, Canada.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Aug 11, 2026. Continuous refresh with full update cycles at least every 30 days.